Skip to main content
OpenTrials

Clinical trial condition

Body Weight

Explore clinical trials studying Body Weight. Study availability and eligibility vary by location and protocol.

11,598 public trials 1,455 recruiting studies
Refine in advanced search Browse all conditions

Body Weight trial results

Completed

A Dose-Range Study of Aleniglipron (GSBR-1290) in Participants Living With Obesity or Overweight With at Least One Weight-related Comorbidity

NCT06703021

Conditions
Body Weight, Chronic Weight Management, Nutrition Disorders, +6 more
Locations
  • ACCESS II Research Site Glendale, California, United States
  • ACCESS II Research Site Montclair, California, United States
  • ACCESS II Research Site Valparaiso, Indiana, United States
  • ACCESS II Research Site West Des Moines, Iowa, United States
View Trial Details
Completed

A Research Study to See How Semaglutide Helps People With Excess Weight and Type 2 Diabetes Lose Weight

NCT05649137

Conditions
Body Weight, Diabetes Mellitus, Diabetes Mellitus, Type 2, +10 more
Locations
  • Univ of Alabama Birmingham Birmingham, Alabama, United States
  • Chambliss Clinical Trials, LLC Montgomery, Alabama, United States
  • John Muir Physicians Network Concord, California, United States
  • Velocity Clinical Research Westlake Los Angeles, California, United States
View all 76 locations
View Trial Details
Completed

A Research Study to See How Semaglutide Helps People With Excess Weight, Lose Weight (STEP UP)

NCT05646706

Conditions
Body Weight, Nutrition Disorders, Nutritional and Metabolic Diseases, +5 more
Locations
  • Univ of Alabama Birmingham Birmingham, Alabama, United States
  • Chambliss Clinical Trials, LLC Montgomery, Alabama, United States
  • Healthscan Clinical Trials,LLC. Montgomery, Alabama, United States
  • Diablo Clinical Research, Inc. Walnut Creek, California, United States
View all 107 locations
View Trial Details
Completed

Comparison of Secukinumab 300 mg Combined With a Lifestyle Intervention to Secukinumab Alone for the Treatment of Moderate to Severe Psoriasis Patients With Concomitant Metabolic Syndrome

NCT03440736

Conditions
Body Weight, Diabetes Mellitus, Endocrine System Diseases, +20 more
Locations
  • Novartis Investigative Site Langenau, Baden-Wurttemberg, Germany
  • Novartis Investigative Site Munich, Bavaria, Germany
  • Novartis Investigative Site Munich, Bavaria, Germany
  • Novartis Investigative Site Darmstadt, Hesse, Germany
View all 75 locations
View Trial Details

Related conditions